Editorial: Combination Cytokine Blockade: The Way Forward in Therapy for Rheumatoid Arthritis?

E-ISSN： 2326-5205|67|1|14-16

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.1, 2015-01, pp. : 14-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Etanercept‐Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 12, 2015-12 ,pp. : 1656-1663

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti‐interleukin‐6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritis

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 1, 2018-01 ,pp. : 194-203

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination Therapy With and Without Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta‐Analysis of Randomized Trials

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 11, 2015-11 ,pp. : 1487-1495

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry

By Weaver Arthur L. Lautzenheiser Richard L. Schiff Michael H. Gibofsky Allan Perruquet James L. Luetkemeyer John Paulus Harold E. Xia H Amy Leff Jonathan A.

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 185-198

Informa Healthcare

Access to resources Recommend Favorite

Protein Array Diagnostics for Guiding Therapy in Rheumatoid Arthritis

By Szodoray Peter

Molecular Diagnosis & Therapy, Vol. 15, Iss. 5, 2011-10 ,pp. : 247-254

Adis International

Access to resources Recommend Favorite